United States · FDA National Drug Code directory

ELEVIDYS

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
60923-503_a96a4f2b-47a9-4175-b3c4-78a0c9350a09
Product NDC
60923-503
Form
KIT
Composition / generic term
delandistrogene moxeparvovec-rokl
Labeler
Sarepta Therapeutics, Inc.
Marketing category
BLA
Marketing start / end (source format)
20230622
Source listing expiry
20271231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 KIT in 1 CARTON (60923-503-12) * 10 mL in 1 VIAL, SINGLE-USE (60923-562-01) * 12 POUCH in 1 BOX / 1 SWAB in 1 POUCH · 60923-503-12

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →